Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate ventriculo-lumbar perfusion chemotherapy for leptomeningeal carcinomatosis (Phase 2)
KCT0000082Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methotrexate in Carcinomatous Meningitis (CM), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jan 2011; status: completed.
02
Drugs
methotrexate
03
Conditions
Carcinomatous Meningitis (CM)
Beyond the preview
Go deeper on KCT0000082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000082.